Gene · 2395
Papers2,919
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,919
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploring the Potential of Scales to Assess Different Types of Ataxia: Meta-review. | Cerebellum | 2026 | 41824138 | PubTator, text mining | PubMed |
| Fifty shades of iron: Unorthodox mechanisms of iron acquisition and utilization in blood-stage Plasmodium parasites. | PLoS Pathog | 2026 | 41805883 | PubTator, text mining | PubMed |
| Targeting Expanded CUG and CTG Repeats as a Therapeutic Approach for Myotonic Dystrophy Type 1 (DM1). | ChemMedChem | 2026 | 41797662 | PubTator, text mining | PubMed |
| Dimethyl fumarate and mitochondrial physiology: implications for neurological disorders. | Front Pharmacol | 2026 | 41769702 | PubTator, text mining | PubMed |
| Coexistence of Friedreich's Ataxia and Esophageal Cancer: A Case Report. | Clin Case Rep | 2026 | 41756699 | PubTator, text mining | PubMed |
| Mesenchymal Stromal Cells and Extracellular Vesicles: A Novel Therapeutic Paradigm for Mitochondrial Dysfunctions. | Int J Mol Sci | 2026 | 41752121 | PubTator, text mining | PubMed |
| Hypoxia, ROS, and HIF Signaling in I/R Injury: Implications and Future Prospects. | Antioxidants (Basel) | 2026 | 41750534 | PubTator, text mining | PubMed |
| Therapeutic Potential of Deferiprone-Resveratrol Hybrid (DFP-RVT) Against Hepatic Iron Overload in β-Thalassemia Mice: A Proteomic Analysis. | Biomolecules | 2026 | 41750406 | PubTator, text mining | PubMed |
| datadrivenhypothesis.org: A resource for metabolic gene discovery through integrated pathway co-essentiality mapping. | bioRxiv | 2026 | 41726868 | PubTator, text mining | PubMed |
| CGG, CAG, and GAA: Genome-wide comparison of the disease linked trinucleotide short tandem repeats. | BMC Genomics | 2026 | 41709137 | PubTator, text mining | PubMed |
| Placental iron utilisation in fetal growth restriction: alterations in mitochondrial haem synthesis and iron-sulphur cluster assembly pathways. | J Physiol | 2026 | 41697720 | PubTator, text mining | PubMed |
| Loss-of-function variants in the CAPN1 activator CD99L2 cause X-linked spastic ataxia. | Nat Commun | 2026 | 41690933 | PubTator, text mining | PubMed |
| Diagnostic yield of genome sequencing in children with progressive movement disorders. | Brain | 2026 | 41640354 | PubTator, text mining | PubMed |
| Hereditary Ataxias: From Pathogenesis and Clinical Features to Neuroimaging, Fluid, and Digital Biomarkers-A Scoping Review. | Int J Mol Sci | 2026 | 41596528 | PubTator, text mining | PubMed |
| Biallelic Truncating DNAH14 Variant in Siblings with Neurodevelopmental Disorder and Predominant Ataxia: Clinical Report and Literature Review. | Int J Mol Sci | 2026 | 41596228 | PubTator, text mining | PubMed |
| Targeting frataxin deficiency in DRG neurons and fibroblasts: omaveloxolone restores metabolic and iron balance to reduce ferroptosis. | Biomed Pharmacother | 2026 | 41579709 | PubTator, text mining | PubMed |
| Integration of Evolutionary Analysis With RFdiffusion for De Novo Design of Aggregation-Resistant Frataxin. | Proteins | 2026 | 41563298 | PubTator, text mining | PubMed |
| [Effect of Biodegradable Mulching Film on Soil Microbial Community in Cotton Field was Revealed Based on Metagenomics]. | Huan Jing Ke Xue | 2026 | 41531093 | PubTator, text mining | PubMed |
| Human pluripotent stem cell models of Friedreich's ataxia: innovations, considerations, and future perspectives. | Stem Cell Res Ther | 2026 | 41514384 | PubTator, text mining | PubMed |
| Organelle-specific regulation of ferroptosis. | Biol Direct | 2026 | 41484993 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2395/papers?page=3